DKK1 and diabetes mellitus: DKK-1 is a recognized classicalWnt signaling inhibitor that is fully participates in theregulation of bone formation and is implicated withthe occurrence and progression of bone metastases.In patients with diabetes, DKK-1 levels are significantlyelevated, which is significantly associated with decreased BMD [11].